Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.

Sub-classes under this class:

Class Number Class Name Patents
424/275.1 Allergen or component thereof (e.g., ragweed pollen, etc.) 278
424/185.1 Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same 2,804
424/234.1 Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) 1,779
424/277.1 Cancer cell or component thereof 576
424/203.1 Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) 297
424/202.1 Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) 298
424/201.1 Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) 210
424/193.1 Conjugate or complex 1,197
424/274.1 Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) 149
424/192.1 Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) 1,553
424/198.1 Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof 706
424/265.1 Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) 341
424/200.1 Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof 345
424/199.1 Recombinant virus encoding one or more heterologous proteins or fragments thereof 833
424/204.1 Virus or component thereof 1,358

Patents under this class:

Patent Number Title Of Patent Date Issued
8709710 Methods of modulating interleukin-22 and immune response by notch regulators Apr. 29, 2014
8709447 Compositions and methods for activating innate and allergic immunity Apr. 29, 2014
8709446 HYR1 as a target for active and passive immunization against Candida Apr. 29, 2014
8709433 Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate Apr. 29, 2014
8703921 Compositions and methods for delivering inhibitory oligonucleotides Apr. 22, 2014
8703908 Expression and export of angiogenesis inhibitors as immunofusins Apr. 22, 2014
8703695 Biologically active peptides and their new uses Apr. 22, 2014
8703432 Recombinant Treponema spp. proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same Apr. 22, 2014
8703153 Salmonella vectored vaccines against Chlamydia and methods of use Apr. 22, 2014
8703152 Methods of treating inflammatory intestinal disease and managing symptoms thereof Apr. 22, 2014
8703151 Tuberculosis vaccines comprising antigens expressed during the latent infection phase Apr. 22, 2014
8703148 Immunogenic composition Apr. 22, 2014
8703147 Methods and compositions for treating and preventing malaria (2) Apr. 22, 2014
8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses Apr. 22, 2014
8703142 Methods to bypass CD4+ cells in the induction of an immune response Apr. 22, 2014
8694265 Bioinformatic approach to disease diagnosis Apr. 8, 2014
8691945 Antimicrobial peptides Apr. 8, 2014
8691752 Protein product for treatment of infectious diseases and related inflammatory processes Apr. 8, 2014
8691502 T-cell vaccination with viral vectors via mechanical epidermal disruption Apr. 8, 2014
8691283 Standardized bee venom preparation Apr. 8, 2014
8691243 Protein-based Streptococcus pneumoniae vaccine Apr. 8, 2014
8691242 Staphylococcus aureus DIV1B for use as vaccine Apr. 8, 2014
8691239 Influenza hemagglutinin and neuraminidase variants Apr. 8, 2014
8691235 Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions Apr. 8, 2014
8691234 Vaccine formulation potentiated by the combination of DNA and an antigen Apr. 8, 2014
8685694 Methods and compositions comprising bacteriophage nanoparticles Apr. 1, 2014
8685670 Isolated chimeric proteins of modified lumazine synthase Apr. 1, 2014
8685413 Heterologous protection against Pasteurella multocida provided by P. multocida fur cells and the outer-membrane protein extracts thereof Apr. 1, 2014
8685412 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing development of calicivirus disease Apr. 1, 2014
8685404 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction Apr. 1, 2014
8685403 Insulin-like growth factor signaling and integrin Apr. 1, 2014
8679540 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications Mar. 25, 2014
8679510 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia Mar. 25, 2014
8679504 Poultry viral materials and methods related thereto Mar. 25, 2014
8679501 Method for modulating inflammatory responses Mar. 25, 2014
8678184 Methods for producing vaccine adjuvants Mar. 25, 2014
8673361 Cytokine modulating composition Mar. 18, 2014
8673318 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions Mar. 18, 2014
8673317 Codon-optimized polynucleotide-based vaccines against human Cytomegalovirus infection Mar. 18, 2014
8673312 Method for one-step purification of recombinant Helicobacter pylori neutrophil-activating protein Mar. 18, 2014
8673311 Bacterial spore having therapeutic agent adsorbed on its surface Mar. 18, 2014
8673293 Use of modified cells for the treatment of multiple sclerosis Mar. 18, 2014
8673289 Attenuated uracil auxotroph of an apicomplexan and use thereof Mar. 18, 2014
8669237 Biodegradable immunomodulatory formulations and methods for use thereof Mar. 11, 2014
8663657 Nucleic acid constructs Mar. 4, 2014
8663651 T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation Mar. 4, 2014
8663650 Methods and compositions comprising supramolecular constructs Mar. 4, 2014
8663644 Augmentation of titer for vaccination in animals Mar. 4, 2014
8658766 Soluble hybrid Fc.gamma. receptors and related methods Feb. 25, 2014
8658592 Biologically active peptides and their new uses Feb. 25, 2014

  Recently Added Patents
Techniques for performing translation of messages
Probe card holding apparatus with probe card engagement structure
Microfluidic system incorporating a metal impregnated nanoporous material in a microfluidic pathway thereof
Therapeutic vitamin D sun-protecting formulations and methods for their use
Stage drive method and stage unit, exposure apparatus, and device manufacturing method
Recording medium, playback device, integrated circuit
Modulation of HSP47 expression
  Randomly Featured Patents
Image input device, image display device, and image display system
PET and SPECT systems with attenuation correction
Vehicle speaker mounting system
Extending time to disease progression or survival in cancer patients
Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof
Wax compositions comprising alkenyl succinic anhydride-capped poly (oxyalkylenated) colorants
Method of and apparatus for testing semiconductor memory
Exhaust gas recirculation control system having a function of automatically correcting detected zero opening value of exhaust gas recirculation valve
System and method facilitating tri-party repurchase agreement transactions
Printing cylinder sleeve assembly